Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS
Neurol 56:1496-1504, Secondary Progressive Efficacy Clinical Trial of R, 2001
Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS
Neurol 56:1505-1513, Li,D.K.B.,et al, 2001
Acute Stroke Patterns in Patients With Internal Carotid Artery Disease
Stroke 32:1323-1329, Szabo,K.,et al, 2001
Repeated Thalamic Haemorrhage: Case Report and Review of the Literature
Acta Neurol Scand 104:48-53, Tatara, N.,et al, 2001
Distribution of Cranial MRI Abnormalities in Patients with Symptomatic and Subclinical CADASIL
BJR 73:256-265, Coulthard, A.,et al, 2000
Progressive Forms of MS:Classification Streamlined or Consensus Overturned?
Lancet 355:162-163, Weinshenker,B.G., 2000
Glatiramer Acetate (Copaxone) Treatment in Relapsing-Remitting MS
Neurol 54:813-817, Ge,Y.,et al, 2000
Primary Neurosarcoidosis:A Diagnostic and Therapeutic Challenge
The Neurologist 6:126-133, Nikhar,N.K.,et al, 2000
Diagnostic Criteria for Primary Progressive Multiple Sclerosis: A Position Paper
Ann Neurol 47:831-835, Thompson,A.J.,et al, 2000
Pseudoulnar Palsy From a Small Infarct of the Precentral Knob
Neurol 54:2185, Phan,T.G.,et al, 2000
How Well Does the Oxfordshire Community Stroke Project Classification Predict the Site and Size of the Infarct on Brain Imaging
JNNP 68:558-562,547, Mead,G.E.,et al, 2000
Motor Strokes Sparing the Leg
Arch Neurol 57:513-518, de Freitas,G.R.,et al, 2000
Cerebrospinal Fluid Oligoclonal IgG Bands in Patients With Spinal Arteriovenous Malformation and Structural Central Nervous System Lesions
Arch Neurol 57:553-557, Cohen,O.,et al, 2000
Multiple Sclerosis--From Probable to Definite Diagnosis
Arch Neurol 57:974-979,930, Achiron,A. & Barak,Y., 2000
Psychological Stress and the Subsequent Appearance of New Brain MRI Lesions in MS
Neurol 55:55-61, Mohr,D.C. et al, 2000
Multiple Sclerosis
NEJM 343:938-952, Noseworthy,J.H. et al, 2000
Relapses and Progression of Disability in Multiple Sclerosis
NEJM 343:1430-1438,1486, Confavreux,C.,et al, 2000
Corpus Callosum Infarcts with Atypical Clinical and Radiologic Presentations
AJNR 21:1876-1880, Kasow,D.L.,et al, 2000
Venous Infarcts
Neurol Neurochir Pol 34:937-946, Mendel,T., 2000
Intracerebral Hemorrhage in Young People,Analysis of Risk Factors,Location,Causes,and Prognosis
Stroke 30:537-541, Rutz-Sandoval,J.L.,et al, 1999
Primary and Transitional Progressive MS,A Clinical and MRI Cross-Sectional Study
Neurol 52:839-845, Stevenson,V.L.,et al, 1999
Interferon-alpha 2a Reduces MRI Disease Activity in Relapsing-Remitting Multiple Sclerosis
Neurol 52:1049-1056, Myhr,K.M.,et al, 1999
Clinicopath Conf:Lymphoplasmocytic Lymphoma with Motor Neuronopathy,Waldenstrom's Macroglobulinemia
NEJM 340:1661-1669, , 1999
Posterior Cerebral Artery Territory Infarcts in the New England Medical Center Posterior Circulation Registry
Arch Neurol 56:824-832, Yamamoto,Y.,et al, 1999
A Longitudinal Study of Brain Atrophy in Relapsing Multiple Sclerosis
Neurol 53:139-148, Simon,J.H.,et al, 1999
Transient MRI Enhancement in a Patient with Seizures and Previously Resected Glioma:Use of MRS
Neurol 53:211-213, Quan,D.,et al, 1999
Benign Multiple Sclerosis? Clinical Course, Long Term Follow Up, and Assessment of Prognostic Factors
JNNP 67:148-152,138, Hawkins,S.A.&McDonnell,G.V., 1999
Magnetic Resonance Imaging Results of the PRISMS Trial:A Randomized, Double-Blind, Placebo-Controlled Study of Interferon-B1a in Relapsing-Remitting Multiple Scleroosis
Ann Neurol 46:197-206, Li,D.K.B.,et al, 1999
Amyloid Myopathy:An Underdiagnosed Entity
Ann Neurol 43:719-728, Spuler,S.,et al, 1999
Sensory Symptoms Restricted to Proximal Body Parts in Small Cortical Infarction
Neurol 53:889-890, Kim,J.S., 1999
Evidence of Interferon B-1a Dose Response In Relapsing-Remitting MS, The OWIMS Study
Neurol 53:679-686, The Once Weekly Interferon for MS Study Group (OWI, 1999
Multiple Sclerosis That is Progressive From the Time of Onset, Clinical Characteristics and Progression of Disability
Arch Neurol 56:1138-1142, Andersson,P.B.,et al, 1999
The Clinical Course of Neuromyelitis Optica (Devic's Syndrome)
Neurol 53:1107-1114, Wingerchuk,D.M.,et al, 1999
Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics
Arch Neurol 56:1079-1084, Rudick,R.A., 1999
Atherothrombotic Cerebellar Infarction, Vascular Lesion-MRI Correlation of 31 Cases
Stroke 30:2376-2381, Min,W.K.,et al, 1999
Stroke Location is Not Associated with Return to Work After First Ischemic Stroke
Stroke 30:2568-2573, Wozniak,M.A.,et al, 1999
Population Based Cost Utility Study of Interferon Beta-1b in Secondary Progressive Multiple Sclerosis
BMJ 319:1529-1533, Forbes,R.B.,et al, 1999
Isolated Weakness of the Fingers in Cortical Infarction
Neurol 50:823-824, Lee,P.,et al, 1998
Extended Use of Glatiramer Acetate (Copaxone) Is Well Tol & Maint Its Clin Effect on MS Relapse Rate & Degree of Disabil
Neurol 50:701-708, Johnson,K.P.,et al, 1998
Intravenous Immunoglobulin Treatment in Multiple Sclerosis, Effect on Relapses
Neurol 50:398-402, Achiron,A.,et al, 1998
Diagnosis of Creutzfeldt-Jakob Disease by Measurement of S100 Protein in Serum:Case-Control Study
BMJ 316:577-581, 5631998., Otto,M.,et al, 1998
Optic Neuritis, Prognosis for Multiple Sclerosis from MRI, CSF, and HLA Findings
Neurol 50:708-714, Soderstrom,M.,et al, 1998
Stroke Patterns of Internal Carotid Artery Dissection in 40 Patients
Stroke 29:2646-2648, Lucas,C.,et al, 1998
Interferon B Therapy for Multiple Sclerosis
Lancet 352:1486-1487, Goodkin,D.E., 1998
Randomised Double-Blind Placebo-Controlled Study of Interferon B-1a in Relapsing/Remitting Multiple Sclerosis
Lancet 352:1498-1504,1486, PRISMS, 1998
Placebo-Controlled Multicentre Randomised Trial of Interferon B-1b in Treatment of Secondary Progressive Multiple Sclerosis
Lancet 352:1491-1497,1486, European Study Group on Interferon B-1b in Seconda, 1998
Clinicopath Conf,Sarcoidosis,with Involvement of Spinal Cord,Brain,Mediastinal Lymph Nodes and ? Lung,Case 35-1998
NEJM 339:1534-1541, , 1998
Arterial Territories of the Human Brain, Cerebral Hemispheres
Neurol 50:1699-1708, Tatu,L.,et al, 1998
Prognosis of patients with Primary Systemic Amyloidosis Who Present with Dominant Neuropathy
Am J Med 104:232-237, Rajkumar,S.V.,et al, 1998
Recurrent Primary Cerebral Hemorrhage, Frequency, Mechanisms, and Prognosis
Stroke 29:1802-1805, Gonzalez-Duarte,A.,et al, 1998